Author: Glenn G. Fort, MD, MPH
Rabies is a fatal zoonotic illness caused by a number of species of neurotropic viruses in the Rhabdoviridae family and transmitted to human beings by the bite of an infected animal.
Approximately one to three U.S. cases annually; 25 human cases of rabies in the U.S. from 2009 to 2018. Of these, seven cases were imported rabies in people who were exposed to rabid animals in endemic nations and one to two cases were in tissue or organ transplantation recipients. Of the 25 cases, 23 died and two survived. In 2021 there were five cases of rabies in the U.S. from bats. Tens of thousands of cases of rabies occur worldwide annually.
In the U.S., most cases are transmitted by bats; in the world, most cases are transmitted by dogs.
BOX E2 Rabies Rigidity/Paralysis:
Differential Diagnosis
From Walls RM et al: Rosens emergency medicine, concepts and clinical practice, ed 10, Philadelphia, 2023, Elsevier.
BOX E1 Differential Diagnosis of Rabies
From Cherry JD et al: Feigin and Cherrys pediatric infectious diseases, ed 8, Philadelphia, 2019, Elsevier.
Figure E1 Decision tree for potential rabies exposures.
(From Walls RM et al: Rosens emergency medicine, concepts and clinical practice, ed 10, Philadelphia, 2023, Elsevier.)
BOX E3 Laboratory Criteria Used to Confirm Rabies
From Walls RM et al: Rosens emergency medicine, concepts and clinical practice, ed 10, Philadelphia, 2023, Elsevier.
TABLE E1 Regimen Examples for Preexposure and Postexposure Vaccination with Rabies Vaccines
Vaccination | Route | Days on Which Doses Are Given | Remarks |
---|---|---|---|
Preexposure | IM* | 0, 7, 21, or 28 | Standard U.S. and WHO three-dose regimen |
ID | 0, 7, 21, or 28 | Economical, but not to be used in those taking antimalarial medications; unlicensed route in U.S.; WHO recommended | |
Postexposure | IM* | 0, 3, 7, 14 | Standard U.S. four-dose recommendation |
IM* | 0 (2 doses), 7, 21 | Used in some countries when RIG is not indicated; so-called 2-1-1 schedule | |
ID | 0, 3, 7 (2 doses each), 28 | Used in Thailand with PVRV, PCECV; so-called 2-2-2-0-1 schedule | |
ID,§ | 0 (8 doses), 7 (4 doses), 28, 90 | Used in developing countries with HDCV, PCECV, or PVRV cell culture vaccines; so-called 8-0-4-0-1-1 | |
Booster (for reexposure) | IM* | 0, 3 | Only after documented vaccination with cell culture vaccine¶ |
ID | 0, 3 | Only after documented vaccination with cell culture vaccine¶ |
HDCV, Human diploid cell vaccine; ID, intradermal; IM, intramuscular; PCECV, purified chick embryo cell vaccine; PVRV, purified Vero cell rabies vaccine; RIG, rabies immune globulin; WHO, World Health Organization.
* Together with rabies immunoglobulin.
Give 0.1 ml, over the deltoids.
Give 0.5 ml (PVRV) or 1 ml, depending on the vaccine, into the deltoid.
§ Give 0.1 ml at multiple sites (see text).
¶ Or demonstrated presence of virus-neutralizing antibodies after other vaccines.
From Cherry JD et al: Feigin and Cherrys pediatric infectious diseases, ed 8, Philadelphia, 2019, Elsevier.